Purchase Order 36C25620P0863
Award Date 5/14/20
Potential Completion Date 9/30/20
Potential Value $119K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Pittsburgh, PA 15275, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Veterans Affairs Veterans Health Administration has awarded a firm fixed price purchase order to Pantherx Specialty LLC, doing business as Pantherx Specialty Pharmacy, to provide the drug Ruzurgi (amifampridine) 10 mg tablets with a potential value of $136,387.44. Pantherx Specialty, a subsidiary of Centene Corporation, is a specialty pharmacy focused on rare diseases that has received multiple federal contract awards from the Department of Justice Bureau of Prisons and the...
- Pantherx Specialty, LLC, doing business as Pantherx Specialty Pharmacy, was awarded a firm fixed-price purchase order valued at $10,896.98 by Veterans Integrated Service Network (VISN) 2, a civilian agency within the Department of Veterans Affairs. The contract, awarded on November 26, 2025, calls for the emergency delivery of TARPEYO (budesonide) 4mg to support the New York Harbor region, with an ultimate completion date of December 26, 2025. The Pittsburgh, Pennsylvania-based specialty...
- This federal contract award, valued at $10,897.20, was issued by the Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs (VA) to Pantherx Specialty, LLC, a for-profit limited liability company and subsidiary of Centene Corporation. The contract is for the delivery of TARPEYO (budesonide) 4mg prescription medication to the New York Harbor. The contract is a firm fixed-price purchase order with a completion date of May 28, 2025. This contract does not have a...
- This federal contract award is for the supply of TARPEYO 4MG drug prescriptions to the New York Harbor Healthcare System, a division of the Department of Veterans Affairs (VA). The $10,897.20 firm fixed price purchase order was awarded to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. Pantherx Specialty is a specialized pharmacy focused on rare diseases and customized medications, and has established itself as a targeted provider of...
- This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian federal agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the emergency provision of TARPEYO 4mg prescription medication, with a ceiling value of $10,896.98 and a performance period ending on November 2, 2025. The contract was awarded on October 2, 2025, and does not have a set-aside...
- The Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a firm fixed-price purchase order to Pantherx Specialty, LLC (doing business as Pantherx Specialty Pharmacy) on October 16, 2025, for TARPEYO 4mg (budesonide), a specialized pharmaceutical product. The contract carries a ceiling value of $10,896.98 and is scheduled for completion by November 17, 2025. This award was not issued under any set-aside designation. Pantherx Specialty, a Pittsburgh-based specialty...
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 2, awarded a firm fixed-price purchase order to Pantherx Specialty, LLC (doing business as Pantherx Specialty Pharmacy) for the provision of TARPEYO medication, valued at $10,896.98. This contract, awarded on November 4, 2025, carries an ultimate completion date of December 31, 2025, and includes no set-aside designation. Performance will take place in Pittsburgh, Pennsylvania, where the prime contractor is...
- The U.S. Department of Veterans Affairs (VA) awarded a $10,897.20 firm fixed price purchase order contract to Pantherx Specialty, LLC, a specialty pharmacy focused on rare diseases, to provide the drug TARPEYO (budesonide) 4mg for an emergency requirement at the New York Harbor VA healthcare facilities. The contract has an ultimate completion date of March 5, 2025. No set-aside designation was used for this award. Pantherx Specialty, a subsidiary of Centene Corporation, is an experienced...
- This is a federal contract award from the Veterans Integrated Service Network (VISN) 2, a civilian agency, to Pantherx Specialty, LLC, a for-profit limited liability company based in Pittsburgh, Pennsylvania. The contract is for the emergency procurement of TARPEYO 4mg prescription medication for the New York Harbor region. The contract is a firm fixed-price purchase order with a ceiling value of $10,896.98 and a period of performance ending on August 16, 2025. Pantherx Specialty is the prime...
- The Department of Veterans Affairs, Veterans Integrated Service Network 2 (VISN 2), awarded a firm fixed-price purchase order to Pantherx Specialty, LLC on December 29, 2025 for TARPEYO medication with a ceiling value of $10,896.98. The contract, which carries no set-aside designation, represents a specialized pharmaceutical supply agreement typical of the contractor's federal business. Performance will occur in Pittsburgh, Pennsylvania, with an ultimate completion date of January 5, 2026....